Clinical Trials Directory

Trials / Completed

CompletedNCT02453516

The Effect of the Serratus Block on Pain Control After Breast Surgery

The Effect of The Serratus Block on Analgesia After Breast Surgery A Randomized Controlled Double-Blinded Study

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Women's College Hospital · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Surgery for breast cancer is associated with significant pain. The serratus nerve block targets the interfascial plane either below or above the serratus muscle, blocking thereby the lateral cutaneous branches of the intercostal nerves. The purpose of this randomized controlled double-blinded study is to see whether the addition of a serratus nerve block to a general anesthesia results in a better postoperative pain control in patients undergoing surgery for breast cancer.

Detailed description

The prevalence of severe acute postoperative pain after breast surgery is high. Regional anesthesia has the potential to provide superior pain relief with fewer side effects compared to standard systemic opioid therapy. The search for a regional anesthesia technique for breast surgery has been ongoing as this technique needs to be time efficient, relatively risk-free and also practicable in an out-patient setting. The serratus block is a promising technique that may combine these advantages.

Conditions

Interventions

TypeNameDescription
PROCEDURESerratus BlockUltrasound-guided nerve block using ropivacaine 0.5% (0.4ml/kg) injected between the serratus anterior and external intercostal muscles
PROCEDUREPlacebo BlockSubcutaneous injection of 1ml sterile normal saline solution in the midaxillary line
DRUGropivacaineDrug indicated for regional anesthesia
DRUGepinephrineDrug indicated to prolong the action of regional anesthesia
OTHERsterile salineNeutral injection (no drug involved)

Timeline

Start date
2014-10-29
Primary completion
2019-09-11
Completion
2019-12-11
First posted
2015-05-25
Last updated
2020-01-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02453516. Inclusion in this directory is not an endorsement.